Princess Catherine Announces Cancer Diagnosis

News
Article

Catherine, Princess of Wales, revealed that she was diagnosed with cancer after undergoing abdominal surgery in January.

Princess Catherine (AKA Katle Middleton) smiles at the camera | Photo credit: Max Mumby/Indigo via Getty Images

Princess Catherine was diagnosed with cancer after abdominal surgery in January.

Photo credit: Max Mumby/Indigo via Getty Images

Catherine, Princess of Wales, (also known as Princess Kate, born Kate Middleton) has been diagnosed with cancer, according to a video message she posted.

“In January, I underwent major abdominal surgery in London and at the time, it was thought that my condition was non-cancerous,” said Catherine. The 42-year-old is married to Prince William, who is the heir to the British throne.

READ MORE:King Charles III Receives Cancer Diagnosis

Catherine explained that her diagnosis was a “huge shock,” and that after the surgery — which she said was successful — further tests were run, which revealed cancer.

“My medical team therefore advised that I should undergo a course of preventative chemotherapy, and I am now in the early stages of that treatment,” she said. “William and I have been doing everything we can to process and manage this privately for the sake of our young family.”

Catherine and William have three children, George, who is 10, Charlotte who is 8 and Louis, who is 5.

Speculation has been ongoing since Catherine’s surgery, after which, she has shied away from the public eye.

“We hope that you will understand that, as a family, we now need some time, space and privacy while I complete my treatment. My work has always brought me a deep sense of joy and I look forward to being back when I am able, but for now I must focus on making a full recovery,” she said.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
Image of Meaghan Mooney at the 2024  Extraordinary Healer Award event.
Video 4 - "Current First-Line Treatment Options in CLL"
Video 3 - "Goals of Treatment for Patients With CLL"
Image of a woman with short blonde hair wearing a white blazer.
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL